US 12,377,083 B2
Lysophosphatidic acid receptor antagonist and preparation method therefor
Jun Lou, Hubei (CN); Yongkai Chen, Hubei (CN); Wei Peng, Hubei (CN); Yihan Zhang, Hubei (CN); Xiaodan Guo, Hubei (CN); Li Liu, Hubei (CN); Junhua Liu, Hubei (CN); Lina Qian, Hubei (CN); and Chaodong Wang, Hubei (CN)
Assigned to WUHAN LL SCIENCE AND TECHNOLOGY DEVELOPMENT CO., LTD., Hubei (CN)
Appl. No. 17/310,092
Filed by WUHAN LL SCIENCE AND TECHNOLOGY DEVELOPMENT CO., LTD., Hubei (CN)
PCT Filed Jan. 15, 2020, PCT No. PCT/CN2020/072186
§ 371(c)(1), (2) Date Jul. 15, 2021,
PCT Pub. No. WO2020/147739, PCT Pub. Date Jul. 23, 2020.
Claims priority of application No. 201910037048.2 (CN), filed on Jan. 15, 2019.
Prior Publication US 2022/0079928 A1, Mar. 17, 2022
Int. Cl. A61K 31/4439 (2006.01); A61K 31/415 (2006.01); A61K 31/4164 (2006.01); A61K 31/42 (2006.01); A61K 31/421 (2006.01); A61K 31/425 (2006.01); A61K 31/426 (2006.01); A61P 11/00 (2006.01); C07D 207/333 (2006.01); C07D 207/34 (2006.01); C07D 213/65 (2006.01); C07D 231/12 (2006.01); C07D 231/16 (2006.01); C07D 231/40 (2006.01); C07D 233/64 (2006.01); C07D 233/68 (2006.01); C07D 235/12 (2006.01); C07D 237/08 (2006.01); C07D 239/26 (2006.01); C07D 261/08 (2006.01); C07D 261/10 (2006.01); C07D 261/14 (2006.01); C07D 261/18 (2006.01); C07D 263/32 (2006.01); C07D 263/34 (2006.01); C07D 275/02 (2006.01); C07D 277/24 (2006.01); C07D 277/64 (2006.01); C07D 401/04 (2006.01); C07D 401/14 (2006.01); C07D 403/04 (2006.01); C07D 413/04 (2006.01)
CPC A61K 31/4439 (2013.01) [A61K 31/415 (2013.01); A61K 31/4164 (2013.01); A61K 31/42 (2013.01); A61K 31/421 (2013.01); A61K 31/425 (2013.01); A61K 31/426 (2013.01); A61P 11/00 (2018.01); C07D 231/12 (2013.01); C07D 233/64 (2013.01); C07D 261/08 (2013.01); C07D 261/14 (2013.01); C07D 263/32 (2013.01); C07D 275/02 (2013.01); C07D 277/24 (2013.01); C07D 401/04 (2013.01); C07D 413/04 (2013.01)] 3 Claims
 
1. A compound, a stereoisomer, a tautomer, a nitrogen oxide, a solvate, a polymorph, an ester, or a pharmaceutically acceptable salt thereof, wherein the compound is selected from the following compounds:

OG Complex Work Unit Chemistry